Sunshine Biopharma Inc. Comprehensive Income
Sunshine Biopharma Inc. (SBFM) reported Comprehensive Income of -$1.88 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-13
- Sunshine Biopharma Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$1.88M.
- Sunshine Biopharma Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$1.52M.
- Sunshine Biopharma Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$1.89M.
- Sunshine Biopharma Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$1.49M.
- Sunshine Biopharma Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$5.21M.
- Sunshine Biopharma Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$6.66M.
- Sunshine Biopharma Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$3.97M.
- Sunshine Biopharma Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$26.56M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.88M 10-Q · filed 2026-08-13 | -$3.40M 10-Q · filed 2026-08-13 | -$5.29M derived: sum of 3 quarters · filed 2026-08-13 | -$6.77M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2026-03-31 | -$1.52M 10-Q · filed 2026-05-13 | -$3.41M derived: sum of 2 quarters · filed 2026-05-13 | -$4.89M derived: sum of 3 quarters · filed 2026-05-13 | -$5.58M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-12-31 | -$1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-03 | -$3.37M derived: sum of 2 quarters · filed 2026-04-03 | -$4.06M derived: sum of 3 quarters · filed 2026-08-13 | -$5.21M 10-K · filed 2026-04-03 | |||
| 2025-09-30 | -$1.49M 10-Q · filed 2025-11-13 | -$2.17M derived: sum of 2 quarters · filed 2026-08-13 | -$3.33M 10-Q · filed 2025-11-13 | -$6.48M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | -$686.28K 10-Q · filed 2026-08-13 | -$1.84M 10-Q · filed 2026-08-13 | -$5.00M derived: sum of 3 quarters · filed 2026-08-13 | -$5.34M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-03-31 | -$1.15M 10-Q · filed 2026-05-13 | -$4.31M derived: sum of 2 quarters · filed 2026-05-13 | -$4.66M derived: sum of 3 quarters · filed 2026-05-13 | -$5.99M derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | -$3.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-03 | -$3.50M derived: sum of 2 quarters · filed 2026-04-03 | -$4.83M derived: sum of 3 quarters · filed 2026-04-03 | -$6.66M 10-K · filed 2026-04-03 | |||
| 2024-09-30 | -$346.16K 10-Q · filed 2025-11-13 | -$1.68M derived: sum of 2 quarters · filed 2025-11-13 | -$3.50M 10-Q · filed 2025-11-13 | -$4.26M derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | -$1.33M 10-Q · filed 2025-08-12 | -$3.16M 10-Q · filed 2025-08-12 | -$3.92M derived: sum of 3 quarters · filed 2025-08-12 | -$5.03M derived: sum of 4 quarters · filed 2025-08-12 | |||
| 2024-03-31 | -$1.83M 10-Q · filed 2025-05-15 | -$2.59M derived: sum of 2 quarters · filed 2025-05-15 | -$3.70M derived: sum of 3 quarters · filed 2025-05-15 | -$4.11M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | -$758.47K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | -$1.87M derived: sum of 2 quarters · filed 2025-04-01 | -$2.28M derived: sum of 3 quarters · filed 2025-04-01 | -$3.97M 10-K · filed 2025-04-01 | |||
| 2023-09-30 | -$1.11M 10-Q · filed 2024-11-05 | -$1.52M derived: sum of 2 quarters · filed 2024-11-05 | -$3.21M 10-Q · filed 2024-11-05 | -$26.48M derived: sum of 4 quarters · filed 2024-11-05 | |||
| 2023-06-30 | -$410.06K 10-Q/A · filed 2024-08-20 | -$2.10M 10-Q/A · filed 2024-08-20 | -$25.37M derived: sum of 3 quarters · filed 2024-08-20 | -$26.87M derived: sum of 4 quarters · filed 2024-08-20 | |||
| 2023-03-31 | -$1.69M 10-Q · filed 2024-05-20 | -$24.96M derived: sum of 2 quarters · filed 2024-05-20 | -$26.46M derived: sum of 3 quarters · filed 2024-05-20 | -$27.02M derived: sum of 4 quarters · filed 2024-05-20 | |||
| 2022-12-31 | -$23.27M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$24.77M derived: sum of 2 quarters · filed 2024-03-28 | -$25.32M derived: sum of 3 quarters · filed 2024-03-28 | -$26.56M 10-K · filed 2024-03-28 | |||
| 2022-09-30 | -$1.50M 10-Q · filed 2023-11-13 | -$2.05M derived: sum of 2 quarters · filed 2023-11-13 | -$3.29M 10-Q · filed 2023-11-13 | -$2.63M derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | -$551.52K 10-Q · filed 2023-08-10 | -$1.79M 10-Q · filed 2023-08-10 | -$1.13M derived: sum of 3 quarters · filed 2023-08-10 | -$5.17M derived: sum of 4 quarters · filed 2023-08-10 | |||
| 2022-03-31 | -$1.24M 10-Q · filed 2023-05-10 | -$573.77K derived: sum of 2 quarters · filed 2023-05-10 | -$4.62M derived: sum of 3 quarters · filed 2023-05-10 | -$7.50M derived: sum of 4 quarters · filed 2023-05-10 | |||
| 2021-12-31 | $661.45K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-04 | -$3.38M derived: sum of 2 quarters · filed 2023-04-04 | -$6.27M derived: sum of 3 quarters · filed 2023-04-04 | -$12.46M 10-K · filed 2023-04-04 | -$12.42M 10-K · filed 2022-03-21 | ||
| 2021-09-30 | -$4.05M 10-Q · filed 2022-11-07 | -$6.93M derived: sum of 2 quarters · filed 2022-11-07 | -$13.12M 10-Q · filed 2022-11-07 | -$14.20M derived: sum of 4 quarters · filed 2022-11-07 | |||
| 2021-06-30 | -$2.89M 10-Q · filed 2022-08-03 | -$9.07M 10-Q · filed 2022-08-03 | -$10.16M derived: sum of 3 quarters · filed 2022-08-03 | -$10.85M derived: sum of 4 quarters · filed 2022-08-03 | |||
| 2021-03-31 | -$6.19M 10-Q · filed 2022-05-06 | -$7.27M derived: sum of 2 quarters · filed 2022-05-06 | -$7.97M derived: sum of 3 quarters · filed 2022-05-06 | -$8.88M derived: sum of 4 quarters · filed 2022-05-06 | |||
| 2020-12-31 | -$1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | -$1.78M derived: sum of 2 quarters · filed 2022-03-21 | -$2.69M derived: sum of 3 quarters · filed 2022-03-21 | -$2.78M 10-K · filed 2022-03-21 | |||
| 2020-09-30 | -$698.74K 10-Q · filed 2021-11-09 | -$1.61M derived: sum of 2 quarters · filed 2021-11-09 | -$1.70M 10-Q · filed 2021-11-09 | -$2.10M derived: sum of 4 quarters · filed 2021-11-09 | |||
| 2020-06-30 | -$906.97K 10-Q · filed 2021-08-09 | -$637.84K 10-Q · filed 2020-08-19 | -$1.00M 10-Q · filed 2021-08-09 | -$733.44K 10-Q · filed 2020-08-19 | -$1.40M derived: sum of 3 quarters · filed 2021-08-09 | -$1.75M derived: sum of 4 quarters · filed 2021-08-09 | |
| 2020-03-31 | -$95.60K 10-Q · filed 2021-05-11 | -$492.57K derived: sum of 2 quarters · filed 2021-05-11 | -$842.93K derived: sum of 3 quarters · filed 2021-05-11 | -$1.55M derived: sum of 4 quarters · filed 2021-05-11 | |||
| 2019-12-31 | -$396.97K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | -$747.33K derived: sum of 2 quarters · filed 2021-03-30 | -$1.46M derived: sum of 3 quarters · filed 2021-03-30 | -$1.66M 10-K · filed 2021-03-30 | |||
| 2019-09-30 | -$350.36K 10-Q · filed 2020-11-12 | -$1.06M derived: sum of 2 quarters · filed 2020-11-12 | -$1.26M 10-Q · filed 2020-11-12 | -$1.61M derived: sum of 4 quarters · filed 2020-11-12 | |||
| 2019-06-30 | -$708.39K 10-Q/A · filed 2020-08-31 | -$911.72K 10-Q/A · filed 2020-08-31 | -$1.26M derived: sum of 3 quarters · filed 2020-08-31 | -$2.16M derived: sum of 4 quarters · filed 2020-08-31 | |||
| 2019-03-31 | -$203.33K 10-Q · filed 2020-05-18 | -$549.46K derived: sum of 2 quarters · filed 2020-05-18 | -$1.45M derived: sum of 3 quarters · filed 2020-05-18 | -$2.10M derived: sum of 4 quarters · filed 2020-05-18 | |||
| 2018-12-31 | -$346.13K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-01 | -$1.25M derived: sum of 2 quarters · filed 2020-05-01 | -$1.89M derived: sum of 3 quarters · filed 2020-05-01 | -$2.16M 10-K · filed 2020-05-01 | |||
| 2018-09-30 | -$899.61K 10-Q · filed 2019-11-13 | -$896.06K 10-Q · filed 2018-11-16 | -$1.55M derived: sum of 2 quarters · filed 2019-11-13 | -$1.81M 10-Q · filed 2019-11-13 | -$2.04M derived: sum of 4 quarters · filed 2019-11-13 | ||
| 2018-06-30 | -$648.36K 10-Q · filed 2019-08-15 | -$915.73K 10-Q · filed 2019-08-15 | -$1.14M derived: sum of 3 quarters · filed 2019-08-15 | -$1.28M derived: sum of 4 quarters · filed 2019-08-15 | |||
| 2018-03-31 | -$268.37K 10-Q · filed 2019-05-20 | -$487.87K derived: sum of 2 quarters · filed 2019-05-20 | -$631.15K derived: sum of 3 quarters · filed 2019-05-20 | -$1.11M derived: sum of 4 quarters · filed 2019-05-20 | |||
| 2017-12-31 | -$219.50K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-12 | -$362.77K derived: sum of 2 quarters · filed 2019-04-12 | -$845.54K derived: sum of 3 quarters · filed 2019-04-12 | -$1.04M 10-K · filed 2019-04-12 | |||
| 2017-09-30 | -$143.28K 10-Q · filed 2018-11-16 | -$626.04K derived: sum of 2 quarters · filed 2018-11-16 | -$820.63K 10-Q · filed 2018-11-16 | -$1.95M derived: sum of 4 quarters · filed 2018-11-16 | |||
| 2017-06-30 | -$482.76K 10-Q · filed 2018-08-17 | -$677.35K 10-Q · filed 2018-08-17 | -$1.80M derived: sum of 3 quarters · filed 2018-08-17 | -$3.39M derived: sum of 4 quarters · filed 2018-08-17 | |||
| 2017-03-31 | -$194.19K 10-Q · filed 2018-05-22 | -$1.32M derived: sum of 2 quarters · filed 2018-05-22 | -$2.91M derived: sum of 3 quarters · filed 2018-05-22 | -$3.38M derived: sum of 4 quarters · filed 2018-05-22 | |||
| 2016-12-31 | -$1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$2.71M derived: sum of 2 quarters · filed 2018-04-02 | -$3.18M derived: sum of 3 quarters · filed 2018-04-02 | -$3.50M 10-K · filed 2018-04-02 | |||
| 2016-09-30 | -$1.59M 10-Q · filed 2017-11-15 | -$2.06M derived: sum of 2 quarters · filed 2017-11-15 | -$2.37M 10-Q · filed 2017-11-15 | -$3.02M derived: sum of 4 quarters · filed 2017-11-15 | |||
| 2016-06-30 | -$469.99K 10-Q · filed 2017-08-11 | -$393.64K 10-Q · filed 2016-08-16 | -$787.94K 10-Q · filed 2017-08-11 | -$698.94K 10-Q · filed 2016-08-16 | -$1.43M derived: sum of 3 quarters · filed 2017-08-11 | -$1.64M derived: sum of 4 quarters · filed 2017-08-11 | |
| 2016-03-31 | -$315.29K 10-Q · filed 2017-05-12 | -$963.35K derived: sum of 2 quarters · filed 2017-05-12 | -$1.17M derived: sum of 3 quarters · filed 2017-05-12 | -$1.68M derived: sum of 4 quarters · filed 2017-05-12 | |||
| 2015-12-31 | -$648.06K derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-17 | -$854.11K derived: sum of 2 quarters · filed 2017-04-17 | -$1.37M derived: sum of 3 quarters · filed 2017-04-17 | -$1.65M 10-K · filed 2017-04-17 | |||
| 2015-09-30 | -$206.05K 10-Q · filed 2016-11-14 | -$719.20K derived: sum of 2 quarters · filed 2016-11-14 | -$1.00M 10-Q · filed 2016-11-14 | -$1.35M derived: sum of 4 quarters · filed 2016-11-14 | |||
| 2015-06-30 | -$513.15K 10-Q · filed 2016-08-16 | -$807.52K 10-Q · filed 2016-08-16 | -$1.14M derived: sum of 3 quarters · filed 2016-08-16 | -$1.42M derived: sum of 4 quarters · filed 2016-08-16 | |||
| 2015-03-31 | -$294.37K 10-Q · filed 2016-05-09 | -$628.08K derived: sum of 2 quarters · filed 2016-05-09 | -$908.93K derived: sum of 3 quarters · filed 2016-05-09 | ||||
| 2014-12-31 | -$333.72K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | -$614.57K derived: sum of 2 quarters · filed 2016-03-25 | -$1.93M 10-K · filed 2016-03-25 | ||||
| 2014-09-30 | -$280.85K 10-Q · filed 2015-11-04 | -$1.60M 10-Q · filed 2015-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |